Takara Bio Inc.
4974.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥1,042,000 | ¥1,481,000 | ¥21,224,000 | ¥27,532,000 |
| Dep. & Amort. | ¥4,481,000 | ¥5,021,000 | ¥4,735,000 | ¥4,149,000 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥1,218,000 | -¥3,788,000 | ¥20,602,000 | -¥19,266,000 |
| Other Non-Cash | ¥1,539,000 | -¥1,003,000 | -¥9,664,000 | -¥5,430,000 |
| Operating Cash Flow | ¥5,844,000 | ¥1,711,000 | ¥36,897,000 | ¥6,985,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥9,871,000 | -¥12,778,000 | -¥5,882,000 | -¥12,539,000 |
| Net Acquisitions | -¥541,000 | ¥0 | ¥396,000 | ¥47,000 |
| Inv. Purchases | -¥1,605,000 | -¥2,224,000 | -¥17,769,000 | -¥11,406,000 |
| Inv. Sales/Matur. | ¥1,511,000 | ¥2,937,000 | ¥16,554,000 | ¥12,877,000 |
| Other Inv. Act. | -¥406,000 | -¥978,000 | ¥8,000 | ¥3,950,000 |
| Investing Cash Flow | -¥10,912,000 | -¥13,043,000 | -¥6,693,000 | -¥7,071,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥0 | ¥0 | -¥151,000 | -¥147,000 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | -¥2,048,000 | -¥5,052,000 | -¥3,968,000 | -¥1,923,000 |
| Other Fin. Act. | -¥208,000 | -¥181,000 | ¥0 | ¥0 |
| Financing Cash Flow | -¥2,256,000 | -¥5,233,000 | -¥4,119,000 | -¥2,070,000 |
| Forex Effect | ¥1,190,000 | ¥678,000 | ¥813,000 | ¥1,008,000 |
| Net Chg. in Cash | -¥6,135,000 | -¥15,887,000 | ¥26,898,000 | -¥1,148,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥33,171,000 | ¥49,058,000 | ¥22,160,000 | ¥23,308,000 |
| End Cash | ¥27,036,000 | ¥33,171,000 | ¥49,058,000 | ¥22,160,000 |
| Free Cash Flow | -¥4,027,000 | -¥11,067,000 | ¥31,015,000 | -¥5,554,000 |